Machine Learning-Based Analysis in the Management of Iatrogenic Bile Duct Injury During Cholecystectomy: a Nationwide Multicenter Study.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
08 2022
Historique:
received: 24 03 2022
accepted: 17 06 2022
pubmed: 6 7 2022
medline: 9 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Iatrogenic bile duct injury (IBDI) is a challenging surgical complication. IBDI management can be guided by artificial intelligence models. Our study identified the factors associated with successful initial repair of IBDI and predicted the success of definitive repair based on patient risk levels. This is a retrospective multi-institution cohort of patients with IBDI after cholecystectomy conducted between 1990 and 2020. We implemented a decision tree analysis to determine the factors that contribute to successful initial repair and developed a risk-scoring model based on the Comprehensive Complication Index. We analyzed 748 patients across 22 hospitals. Our decision tree model was 82.8% accurate in predicting the success of the initial repair. Non-type E (p < 0.01), treatment in specialized centers (p < 0.01), and surgical repair (p < 0.001) were associated with better prognosis. The risk-scoring model was 82.3% (79.0-85.3%, 95% confidence interval [CI]) and 71.7% (63.8-78.7%, 95% CI) accurate in predicting success in the development and validation cohorts, respectively. Surgical repair, successful initial repair, and repair between 2 and 6 weeks were associated with better outcomes. Machine learning algorithms for IBDI are a novel tool may help to improve the decision-making process and guide management of these patients.

Sections du résumé

BACKGROUND
Iatrogenic bile duct injury (IBDI) is a challenging surgical complication. IBDI management can be guided by artificial intelligence models. Our study identified the factors associated with successful initial repair of IBDI and predicted the success of definitive repair based on patient risk levels.
METHODS
This is a retrospective multi-institution cohort of patients with IBDI after cholecystectomy conducted between 1990 and 2020. We implemented a decision tree analysis to determine the factors that contribute to successful initial repair and developed a risk-scoring model based on the Comprehensive Complication Index.
RESULTS
We analyzed 748 patients across 22 hospitals. Our decision tree model was 82.8% accurate in predicting the success of the initial repair. Non-type E (p < 0.01), treatment in specialized centers (p < 0.01), and surgical repair (p < 0.001) were associated with better prognosis. The risk-scoring model was 82.3% (79.0-85.3%, 95% confidence interval [CI]) and 71.7% (63.8-78.7%, 95% CI) accurate in predicting success in the development and validation cohorts, respectively. Surgical repair, successful initial repair, and repair between 2 and 6 weeks were associated with better outcomes.
DISCUSSION
Machine learning algorithms for IBDI are a novel tool may help to improve the decision-making process and guide management of these patients.

Identifiants

pubmed: 35790677
doi: 10.1007/s11605-022-05398-7
pii: 10.1007/s11605-022-05398-7
pmc: PMC9439981
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1713-1723

Informations de copyright

© 2022. The Author(s).

Références

Ann Surg. 2017 Jun;265(6):1045-1050
pubmed: 28486288
Surg Endosc. 2021 Apr;35(4):1651-1658
pubmed: 32306111
HPB (Oxford). 2011 Jan;13(1):1-14
pubmed: 21159098
J Hepatobiliary Pancreat Sci. 2019 Apr;26(4):123-127
pubmed: 30828991
Surg Endosc. 2021 Mar;35(3):1088-1092
pubmed: 32107631
Ann Surg. 2007 May;245(5):763-70
pubmed: 17457169
Ann Surg. 2013 Sep;258(3):490-9
pubmed: 24022441
J Gastrointest Surg. 2021 Nov;25(11):2796-2805
pubmed: 33532980
Br J Surg. 2014 Jan;101(2):63-8
pubmed: 24318962
Br J Surg. 2008 Apr;95(4):460-5
pubmed: 18161898
Ann Surg. 2020 Jul;272(1):3-23
pubmed: 32404658
Ann Surg. 2020 Mar;271(3):449-459
pubmed: 32106173
Surg Endosc. 2021 Jun;35(6):2879-2888
pubmed: 32572630
Surgery. 2018 May;163(5):1121-1127
pubmed: 29475612
Surg Clin North Am. 2019 Apr;99(2):283-299
pubmed: 30846035
Ann Surg. 2016 Sep;264(3):544-53
pubmed: 27433902
J Hepatobiliary Pancreat Sci. 2017 Nov;24(11):591-602
pubmed: 28884962
HPB (Oxford). 2019 Dec;21(12):1641-1647
pubmed: 31151812
Hepatobiliary Pancreat Dis Int. 2021 Feb;20(1):53-60
pubmed: 33268245
J Visc Surg. 2013 Jun;150(3 Suppl):S33-8
pubmed: 23791984
N Engl J Med. 2017 Jun 29;376(26):2507-2509
pubmed: 28657867
Surg Endosc. 2018 Mar;32(3):1184-1191
pubmed: 28840410
J Am Coll Surg. 2014 Nov;219(5):923-32.e10
pubmed: 25127511
Am J Gastroenterol. 2020 Aug;115(8):1191-1198
pubmed: 32483004
HPB (Oxford). 2017 Apr;19(4):352-358
pubmed: 28189346
EBioMedicine. 2019 Aug;46:27-29
pubmed: 31303500
Ann Surg. 1997 May;225(5):459-68; discussion 468-71
pubmed: 9193174
HPB (Oxford). 2016 Dec;18(12):1010-1016
pubmed: 27773464
Ann Surg. 2018 Jul;268(1):143-150
pubmed: 28426479
BMJ. 2020 Mar 25;368:m689
pubmed: 32213531

Auteurs

Victor Lopez-Lopez (V)

Department of Surgery and Transplantation, Virgen de La Arrixaca Clinic and University Hospital, Murcian Institute of Biosanitary Research (IMIB), Ctra. Madrid-Cartagena, 30120, s/nEl Palmar, Murcia, Spain. victorrelopez@gmail.com.

Javier Maupoey (J)

Department of Hepatobiliary Surgery and Transplants, Hospital Universitario La Fe, Valencia, Spain.

Rafael López-Andujar (R)

Department of Hepatobiliary Surgery and Transplants, Hospital Universitario La Fe, Valencia, Spain.

Emilio Ramos (E)

Department of Hepatobiliary Surgery and Liver Transplant Unit, Hospital Universitari Bellvitge, University of Barcelona, Barcelona, Spain.

Kristel Mils (K)

Department of Hepatobiliary Surgery and Liver Transplant Unit, Hospital Universitari Bellvitge, University of Barcelona, Barcelona, Spain.

Pedro Antonio Martinez (PA)

Department of Information and Communication Engineering, Universidad de Murcia, Murcia, Spain.

Andres Valdivieso (A)

Hepatobiliary Surgery and Liver Transplant Unit, Cruces University Hospital, Bilbao, Spain.

Marina Garcés-Albir (M)

Department of Surgery, Hospital Clínico, University of Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.

Luis Sabater (L)

Department of Surgery, Hospital Clínico, University of Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.

Luis Díez Valladares (LD)

Department of Surgery, Hepatopancreatobiliary Unit, Hospital Clínico San Carlos, Madrid, Spain.

Sergio Annese Pérez (SA)

Department of Surgery, Morales University Hospital, Madrid, Spain.

Benito Flores (B)

Department of Surgery, Morales University Hospital, Madrid, Spain.

Roberto Brusadin (R)

Department of Surgery and Transplantation, Virgen de La Arrixaca Clinic and University Hospital, Murcian Institute of Biosanitary Research (IMIB), Ctra. Madrid-Cartagena, 30120, s/nEl Palmar, Murcia, Spain.

Asunción López Conesa (AL)

Department of Surgery and Transplantation, Virgen de La Arrixaca Clinic and University Hospital, Murcian Institute of Biosanitary Research (IMIB), Ctra. Madrid-Cartagena, 30120, s/nEl Palmar, Murcia, Spain.

Valentin Cayuela (V)

Department of Surgery and Transplantation, Virgen de La Arrixaca Clinic and University Hospital, Murcian Institute of Biosanitary Research (IMIB), Ctra. Madrid-Cartagena, 30120, s/nEl Palmar, Murcia, Spain.

Sagrario Martinez Cortijo (SM)

Department of Surgery, Alcorcon University Hospital, Madrid, Spain.

Sandra Paterna (S)

Department of Surgery, Miguel Servet University Hospital, Saragossa, Spain.

Alejando Serrablo (A)

Department of Surgery, Miguel Servet University Hospital, Saragossa, Spain.

Santiago Sánchez-Cabús (S)

Hepatobiliopancreatic Surgery Unit, Hospital de La Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Antonio González Gil (AG)

Department of Surgery, Los Arcos del Mar Menor University Hospital, Murcia, Spain.

Jose Antonio González Masía (JAG)

Department of Surgery, General University Hospital, Albacete, Spain.

Carmelo Loinaz (C)

Department of General Surgery, Digestive Tract and Abdominal Organ Transplantation, Hospital Universitario, 12 de Octubre, Madrid, Spain.

Jose Luis Lucena (JL)

Department of Surgery, Puerta del Hierro University Hospital, Madrid, Spain.

Patricia Pastor (P)

Department of Surgery, Reina Sofía University Hospital, Murcia, Spain.

Cristina Garcia-Zamora (C)

Department of Surgery, Rafael Mendez Hospital, Murcia, Spain.

Alicia Calero (A)

Department of General Surgery, Elche University Hospital, University Miguel Hernández of Elche, Alicante, Spain.

Juan Valiente (J)

Department of General Surgery, Hellin Hospital, Albacete, Spain.

Antonio Minguillon (A)

Department of General Surgery, Obispo Polanco Hospital, Teruel, Spain.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, Department of General Surgery, Clinica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Jose Manuel Ramia (JM)

HPB Surgery and Liver Transplantation, Dr. Balmis General University Hospital, and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.

Cándido Alcazar (C)

HPB Surgery and Liver Transplantation, Dr. Balmis General University Hospital, and Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.

Javier Aguilo (J)

Department of General Surgery, Hospital Lluís Alcanyís Hospital, Xàtiva, Valencia, Spain.

Jose Cutillas (J)

Department of General Surgery, Hospital Francesc de Borja, Gandía, Valencia, Spain.

Christoph Kuemmerli (C)

Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland.
Department of Surgery, Clarunis - University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.

Jose A Ruiperez-Valiente (JA)

Department of Information and Communication Engineering, Universidad de Murcia, Murcia, Spain.

Ricardo Robles-Campos (R)

Department of Surgery and Transplantation, Virgen de La Arrixaca Clinic and University Hospital, Murcian Institute of Biosanitary Research (IMIB), Ctra. Madrid-Cartagena, 30120, s/nEl Palmar, Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH